Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs) for human biomonitoring of perfluoroalkyl substances (PFASs) in serum as part of the quality assurance programme under HBM4EU

Ateia, 2019, The overlooked short- and ultrashort-chain poly- and perfluorinated substances: a review, Chemosphere, 220, 866, 10.1016/j.chemosphere.2018.12.186 Blake, 2020, Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: a review including the placenta as a target tissue and possible driver of peri- and postnatal effects, Toxicology, 443, 10.1016/j.tox.2020.152565 Brede, 2010, Two-year follow-up biomonitoring pilot study of residents‘ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany, Int. J. Hyg. Environ. Health, 213, 217, 10.1016/j.ijheh.2010.03.007 Buck, 2011, Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origin, Integr. Environ. Assess. Manag., 7, 513, 10.1002/ieam.258 Chambers, 2021, A review of per- and Polyfluorinated alkyl substance impairment of reproduction, Front. Toxicol., 3, 10.3389/ftox.2021.732436 Clara, 2008, Emissions of perfluorinated alkylated substances (PFAS) from point sources – identification of relevant branches, Water Sci. Technol., 58, 59, 10.2166/wst.2008.641 De Silva, 2021, PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding, Environ. Toxicol. Chem., 40, 631, 10.1002/etc.4935 Domingo, 2017, Per- and polyfluoroalkyl substances (PFASs) in food and human dietary intake: a review of the recent scientific literature, J. Agric. Food Chem., 65, 533, 10.1021/acs.jafc.6b04683 EFSA Panel on Contaminants in the Food Chain (EFSA CONTAM Panel), 2020, Risk to human health related to the presence of perfluoroalkyl substances in food, EFSA J., 18, 10.2903/j.efsa.2020.6223 Esteban López, 2021, The european human biomonitoring platform - design and implementation of a QA/QC programme for selected priority chemicals, Int. J. Hyg. Environ. Health, 234, 10.1016/j.ijheh.2021.113740 Fearn, 2001, A new test for 'sufficient homogeneity', Analyst, 126, 1414, 10.1039/b103812p Fiedler, 2020, Global interlaboratory assessments of perfluoroalkyl substances under the Stockholm convention on persistent organic pollutants, Trends Anal. Chem., 124, 10.1016/j.trac.2019.03.023 Ganzleben, 2017, Human biomonitoring as a tool to support chemicals regulation in the European Union, Int. J. Hyg. Environ. Health, 220, 94, 10.1016/j.ijheh.2017.01.007 Gilles, 2021, HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - the HBM4EU survey, Int. J. Hyg. Environ. Health, 237, 10.1016/j.ijheh.2021.113809 Glüge, 2020, An overview on the uses of per- and polyfluoroalkyl substances (PFAS), Environ Sci Processes Impacts, 22, 2345, 10.1039/D0EM00291G Göen, 2012, External quality assessment of human biomonitoring in the range of environmental exposure levels, Int. J. Hyg. Environ. Health, 215, 229, 10.1016/j.ijheh.2011.08.012 2017 Ingelido, 2018, Biomonitoring of perfluorinated compounds in adults exposed to contamined drinking water in the Veneto Region, Italy, Environ. Int., 110, 149, 10.1016/j.envint.2017.10.026 Kotthoff, 2015, Perfluoroalkyl and polyfluroalkyl substances in consumer products, Environ. Sci. Pollut. Res., 22, 14546, 10.1007/s11356-015-4202-7 Louro, 2019, Human biomonitoring in health risk assessment in Europe: current practices and recommendations for the future, Int. J. Hyg. Environ. Health, 222, 727, 10.1016/j.ijheh.2019.05.009 Meegoda, 2020, A review of the applications, environmental release, and remediation technologies of per- and polyfluoroalkyl substances, Int. J. Environ. Res. Public Health, 17, 8117, 10.3390/ijerph17218117 Mol, 2022, Proficiency and interlaboratory variability for the determination of phthalate and DINCH biomarkers in human urine: results from the HBM4EU project, Toxics, 10, 57, 10.3390/toxics10020057 Nübler, 2021, Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood:results from the HBM4EU project, Int. J. Hyg. Environ. Health, 234, 10.1016/j.ijheh.2021.113711 Nübler, 2022, Interlaboratory comparison investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU, J. Trace Elem. Med. Biol., 70, 10.1016/j.jtemb.2021.126912 Panieri, 2022, PFAS molecules: a major concern for the human health and the environment, Toxics, 10, 44, 10.3390/toxics10020044 Pirard, 2020, Background contaminantion of perfluoralkyl substances in a Belgium general population, Toxicol. Lett., 333, 13, 10.1016/j.toxlet.2020.07.015 Seals, 2011, Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community, Environ. Health Perspect., 119, 119, 10.1289/ehp.1002346 Thompson, 2000, Recent trends in inter-laboratory precision at ppb and sub-ppb concentrations in relation to fitness for purpose criteria in proficiency testing, Analyst, 125, 385, 10.1039/b000282h Thompson, 2006, The international harmonized protocol for the proficiency testing of analytical chemistry laboratories, Pure Appl. Chem., 78, 145, 10.1351/pac200678010145 Trier, 2011, Polyfluorinated surfactants (PFS) in paper and board coatings for food packing, Environ. Sci. Pollut. Res., 18, 1108, 10.1007/s11356-010-0439-3 Vorkamp, 2021, Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a european human biomonitoring initiative, Environ. Int., 146, 10.1016/j.envint.2020.106082 Weiss, 2013, Analytical improvements shown over four interlaboratory studies of perfluoroalkyl substances in environmental and food samples, Trends Anal. Chem., 43, 204, 10.1016/j.trac.2012.10.005 Xu, 2021, Serum perfluoroalkyl substances in residents following long-term drinking water contamination from firefighting foam in Ronneby, Sweden, Environ. Int., 147, 10.1016/j.envint.2020.106333